# Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke

Study · id `cardio:ct-nct05565781` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05565781](<https://clinicaltrials.gov/study/NCT05565781>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05565781

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05565781. Randomized; no masking; primary purpose screening. Start 2022-03-28 (actual); primary completion 2025-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05565781, source copy `cardio:ctgov-nct05565781-2025-04-04`, retrieved 2026-10-26)
- Started: 2022-03-28 (actual) (ClinicalTrials.gov record NCT05565781, source copy `cardio:ctgov-nct05565781-2025-04-04`, retrieved 2026-10-26)
- Primary completion: 2025-06-01 (anticipated) (ClinicalTrials.gov record NCT05565781, source copy `cardio:ctgov-nct05565781-2025-04-04`, retrieved 2026-10-26)
- Completion: 2026-09-01 (anticipated) (ClinicalTrials.gov record NCT05565781, source copy `cardio:ctgov-nct05565781-2025-04-04`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT05565781, source copy `cardio:ctgov-nct05565781-2025-04-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05565781-2025-04-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke
- Acronym: SMARTTHUNDER
- Condition: Paroxysmal Atrial Fibrillation
- Condition: Cryptogenic Stroke
- Intervention (Device): ECG smartwatch
- Intervention (Device): Insertable Cardiac Monitor (ICM)
- Intervention (Device): External ECG Monitoring
- Lead sponsor: Hospital Universitari Vall d'Hebron Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Hospital Universitari Vall d'Hebron Research Institute (`cardio:org-hospital-universitari-vall-d-hebron-research-institute`)

## Provenance

Content hash: 3754d64616805400a6709001d2ea9db049597963c3949f3f2b2ef950d9a2a009
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
